A look back at the week's news.
Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.
Best practices on discussing birth control for adolescents.
If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).
Check out these latest resources from the American Urogynecologic Society.
Changes for ICD-10 documentation codes that go into effect in October 2022.
Tips to avoid wasting time and optimize meetings you do need.